Search research articles
Contact Us
Filters
Showing results (51-60 of 110) with videos related to
Page
of 11
Sort By:
Carcinogenesis
|
November 7, 1998
The rodent non-genotoxic hepatocarcinogen nafenopin suppresses apoptosis preferentially in non-cycling hepatocytes but also elevates CDK4, a cell cycle progression factor
J H Gill, P Brickell, C Dive, et al.
Trends in Pharmacological Sciences
|
February 2, 2010
Gender differences in drug toxicity
Tamara J Nicolson, Howard R Mellor, Ruth R A Roberts
Hepatology (Baltimore, Md.)
|
September 26, 2000
Transforming growth factor-beta(1) induces apoptosis in rat FaO hepatoma cells via cytochrome c release and oligomerization of Apaf-1 to form a approximately 700-kd apoptosome caspase-processing complex
C Freathy, D G Brown, R A Roberts, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 28, 2000
Nafenopin causes protein kinase C-mediated serine phosphorylation and loss of function of connexin 32 protein in rat hepatocytes without aberrant expression or localization
F J Elcock, E Deag, R A Roberts, et al.
Transplantation
|
May 1, 1988
Renal transplantation in secondary oxalosis
R A Roberts, I S Sketris, A S MacDonald, et al.
Carcinogenesis
|
March 14, 1998
The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and Fas
J H Gill, N H James, R A Roberts, et al.
Journal of Cell Science
|
February 1, 1993
Non-genotoxic hepatocarcinogenesis in vitro: the FaO hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis
A C Bayly, N J French, C Dive, et al.
Carcinogenesis
|
January 3, 2001
Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro
S C Hasmall, D A West, K Olsen, et al.
The Journal of Pediatrics
|
June 1, 1996
Serum erythropoietin levels during infancy: associations with erythropoiesis
P J Kling, R L Schmidt, R A Roberts, et al.
Asian Pacific Journal of Allergy and Immunology
|
April 1, 2006
Immune dysfunction in Australian Aborigines
P J Roberts-Thomson, R A Roberts-Thomson, T Nikoloutsopoulos, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 110) with videos related to
Sort By:
Page
of 11
Carcinogenesis
|
November 7, 1998
The rodent non-genotoxic hepatocarcinogen nafenopin suppresses apoptosis preferentially in non-cycling hepatocytes but also elevates CDK4, a cell cycle progression factor
J H Gill, P Brickell, C Dive, et al.
Trends in Pharmacological Sciences
|
February 2, 2010
Gender differences in drug toxicity
Tamara J Nicolson, Howard R Mellor, Ruth R A Roberts
Hepatology (Baltimore, Md.)
|
September 26, 2000
Transforming growth factor-beta(1) induces apoptosis in rat FaO hepatoma cells via cytochrome c release and oligomerization of Apaf-1 to form a approximately 700-kd apoptosome caspase-processing complex
C Freathy, D G Brown, R A Roberts, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 28, 2000
Nafenopin causes protein kinase C-mediated serine phosphorylation and loss of function of connexin 32 protein in rat hepatocytes without aberrant expression or localization
F J Elcock, E Deag, R A Roberts, et al.
Transplantation
|
May 1, 1988
Renal transplantation in secondary oxalosis
R A Roberts, I S Sketris, A S MacDonald, et al.
Carcinogenesis
|
March 14, 1998
The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and Fas
J H Gill, N H James, R A Roberts, et al.
Journal of Cell Science
|
February 1, 1993
Non-genotoxic hepatocarcinogenesis in vitro: the FaO hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis
A C Bayly, N J French, C Dive, et al.
Carcinogenesis
|
January 3, 2001
Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro
S C Hasmall, D A West, K Olsen, et al.
The Journal of Pediatrics
|
June 1, 1996
Serum erythropoietin levels during infancy: associations with erythropoiesis
P J Kling, R L Schmidt, R A Roberts, et al.
Asian Pacific Journal of Allergy and Immunology
|
April 1, 2006
Immune dysfunction in Australian Aborigines
P J Roberts-Thomson, R A Roberts-Thomson, T Nikoloutsopoulos, et al.
Page
of 11